XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Adjustment From Adoption of ASC 842
Public offering
2019 Stock purchase agreement
2017 At-the-market
Common Stock
Common Stock
Public offering
Common Stock
2019 Stock purchase agreement
Common Stock
2017 At-the-market
Additional Paid-in Capital
Additional Paid-in Capital
Public offering
Additional Paid-in Capital
2019 Stock purchase agreement
Additional Paid-in Capital
2017 At-the-market
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Accumulated Deficit
Adjustment From Adoption of ASC 842
Beginning balance (in shares) at Dec. 31, 2018           30,839,463                    
Beginning balance at Dec. 31, 2018 $ 51,344         $ 308       $ 177,335       $ (3) $ (126,296)  
Stockholders’ deficit                                
Issuance of common stock, net of issuance cost (in shares)                 47,589              
Issuance of common stock, net of issuance cost         $ 134       $ 1       $ 133      
Issuance of common stock for cash under employee stock purchase plan (in shares)           34,167                    
Issuance of common stock for cash under employee stock purchase plan 84                 84            
Share-based compensation expense 1,018                 1,018            
Change in unrealized gain on investments 5                         5    
Net loss (11,629)                           (11,629)  
Ending balance (in shares) at Mar. 31, 2019           30,921,219                    
Ending balance at Mar. 31, 2019 40,956         $ 309       178,570       2 (137,925)  
Beginning balance (in shares) at Dec. 31, 2018           30,839,463                    
Beginning balance at Dec. 31, 2018 51,344         $ 308       177,335       (3) (126,296)  
Stockholders’ deficit                                
Change in unrealized gain on investments 14                              
Net loss (20,525)                              
Ending balance (in shares) at Jun. 30, 2019           31,037,363                    
Ending balance at Jun. 30, 2019 33,437         $ 310       179,937       11 (146,821)  
Beginning balance (in shares) at Dec. 31, 2018           30,839,463                    
Beginning balance at Dec. 31, 2018 $ 51,344         $ 308       177,335       (3) (126,296)  
Ending balance (in shares) at Dec. 31, 2019 34,861,876         34,861,876                    
Ending balance at Dec. 31, 2019 $ 15,754 $ (3)       $ 349       183,574       0 (168,169) $ (3)
Stockholders’ deficit                                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member                              
Beginning balance (in shares) at Mar. 31, 2019           30,921,219                    
Beginning balance at Mar. 31, 2019 $ 40,956         $ 309       178,570       2 (137,925)  
Stockholders’ deficit                                
Issuance of common stock, net of issuance cost (in shares)           96,652                    
Issuance of common stock, net of issuance cost 278         $ 1       277            
Shares issued for cash upon the exercise of stock options (in shares)           19,492                    
Shares issued for cash upon the exercise of stock options under an equity incentive plan 15                 15            
Share-based compensation expense 1,075                 1,075            
Change in unrealized gain on investments 9                         9    
Net loss (8,896)                           (8,896)  
Ending balance (in shares) at Jun. 30, 2019           31,037,363                    
Ending balance at Jun. 30, 2019 $ 33,437         $ 310       179,937       11 (146,821)  
Beginning balance (in shares) at Dec. 31, 2019 34,861,876         34,861,876                    
Beginning balance at Dec. 31, 2019 $ 15,754 (3)       $ 349       183,574       0 (168,169) (3)
Stockholders’ deficit                                
Issuance of common stock, net of issuance cost (in shares)             15,000,000 2,200,000 975,063              
Issuance of common stock, net of issuance cost     $ 13,881 $ 4,049 $ 670   $ 150 $ 22 $ 10   $ 13,731 $ 4,027 $ 660      
Shares issued for cash upon the exercise of stock options (in shares)           17,238                    
Shares issued for cash upon the exercise of stock options under an equity incentive plan 13                 13            
Issuance of common stock for cash under employee stock purchase plan (in shares)           23,171                    
Issuance of common stock for cash under employee stock purchase plan 16                 16            
Share-based compensation expense 664                 664            
Net loss (8,044)                           (8,044)  
Ending balance (in shares) at Mar. 31, 2020           53,077,348                    
Ending balance at Mar. 31, 2020 $ 27,000         $ 531       202,685       0 (176,216)  
Beginning balance (in shares) at Dec. 31, 2019 34,861,876         34,861,876                    
Beginning balance at Dec. 31, 2019 $ 15,754 $ (3)       $ 349       183,574       0 (168,169) $ (3)
Stockholders’ deficit                                
Issuance of common stock for cash under employee stock purchase plan (in shares)           145,061                    
Change in unrealized gain on investments 0                              
Net loss $ (14,479)                              
Ending balance (in shares) at Jun. 30, 2020 53,077,348         53,077,348                    
Ending balance at Jun. 30, 2020 $ 21,171         $ 531       203,291       0 (182,651)  
Beginning balance (in shares) at Mar. 31, 2020           53,077,348                    
Beginning balance at Mar. 31, 2020 27,000         $ 531       202,685       0 (176,216)  
Stockholders’ deficit                                
Issuance costs related to public offering     $ (17)               $ (17)          
Share-based compensation expense 623                 623            
Change in unrealized gain on investments 0                              
Net loss $ (6,435)                           (6,435)  
Ending balance (in shares) at Jun. 30, 2020 53,077,348         53,077,348                    
Ending balance at Jun. 30, 2020 $ 21,171         $ 531       $ 203,291       $ 0 $ (182,651)